What GFSI Auditors Typically Expect from Food‑Plant Microbiology Programs

Key Takeaways

GFSI auditors assess whether your microbiology program is risk driven, documented, and anchored to accredited laboratory methods, not just whether tests are scheduled and completed.
ISO 17025 accreditation and recognized methods are now baseline expectations for food safety critical microbiology testing under major GFSI schemes.
Environmental monitoring programs are a primary focus in audits, especially in RTE and high care areas, with auditors scrutinizing zone design, sampling frequencies, target organisms, and corrective action records.
The most common major findings come from weak lab governance, fragmented testing programs, and poor integration of results into hazard analysis, trend analysis, and management review.
Leaders who treat microbiology as a strategic risk management system, not a compliance chore, are better positioned to protect certification, brand, and regulatory relationships.

Article at a Glance

GFSI benchmarked schemes such as BRCGS, SQF, FSSC 22000, and PrimusGFS have raised the bar for what a microbiology program must look like in a certified food plant. Auditors are trained to evaluate whether your program can detect and control microbiological hazards in time to prevent consumer exposure, not just whether you can produce binders of laboratory reports.

For mid sized manufacturers, the pressure comes from two sides. Certification bodies apply scheme clauses on laboratory competence, environmental monitoring, product testing, and validation, while major retail and foodservice customers layer their own expectations on top. A gap in your microbiology program can delay certification, trigger customer reviews, and, in more serious cases, expose you to CFIA, Health Canada, or FDA attention.

The core of audit defensibility is a program that is designed and governed as a system. That means ISO 17025 accredited lab partners, recognized methods, risk based sampling plans, an environmental monitoring program designed to find problems, and a clear link from test results to hazard analysis, investigations, and management decisions. Executives who understand these expectations can allocate resources, set governance routines, and work with lab partners to reduce the likelihood of disruptive findings.

The Leadership Stakes Behind GFSI Microbiology Expectations

Why microbiology is where audits are won or lost

Most food plant leaders understand that GFSI certification is a ticket to major retail and foodservice markets. The nuance is that the microbiology program is often where an otherwise solid audit turns into a major nonconformance. When a certification body auditor walks into your plant, they are asking a simple question: can this facility detect and control microbiological hazards before they reach consumers?

For QA directors, plant managers, and regulatory leads working under BRCGS, SQF, FSSC 22000, or PrimusGFS, the consequences are concrete. A major nonconformance in environmental monitoring, finished product testing, or laboratory governance does not just reduce your score. It can delay or suspend certification, trigger formal corrective action plans, and force uncomfortable conversations with retail buyers and brand owners. If findings relate to hazards such as Listeria monocytogenes or Salmonella, they can also intersect with CFIA or FDA oversight.

Brand, regulatory, and financial exposure

When a microbiology program fails during a GFSI audit, the impact is rarely limited to the report. Typical knock on effects include:

Mandatory corrective action timelines that pull resources away from operations and projects.
Temporary suspension or downgrade of certification status that must be disclosed to customers.
Customer initiated audits or sourcing reviews that tie up leadership and technical teams.
Increased regulatory scrutiny if the gap involves verification of a regulated hazard.

A single recall, driven by undetected pathogen contamination, usually dwarfs several years of investment in a robust microbiology program. Direct costs, lost production, retailer penalties, and damage to brand reputation can reshape a company’s risk appetite for years. Treating microbiology expectations as a strategic risk management issue, rather than an audit checkbox, is a rational leadership response.

Cremco Labs works with QA and food safety teams at mid sized manufacturers to design audit defensible microbiology programs that align with CFIA, Health Canada, FSMA, and GFSI expectations, using ISO 17025 accredited testing and structured documentation support.

How GFSI Schemes Shape Expectations For Your Microbiology Program

What GFSI actually does

GFSI does not certify plants directly. It benchmarks food safety schemes against its Guidance Document and recognizes those that meet its criteria. The schemes most relevant to Canadian and North American manufacturers, such as BRCGS Food Safety, SQF Edition 9, FSSC 22000, and PrimusGFS, all contain explicit requirements for microbiological testing and environmental monitoring.

These scheme clauses cover:

Finished product testing to verify that processes and controls are working.
Raw material and ingredient testing based on risk.
Environmental monitoring, particularly in RTE, high care, and high risk areas.
Laboratory competence and, in practice, ISO 17025 accreditation.
Validation and verification of controls that rely on microbiological lethality or growth control.

Retail and foodservice customers who require GFSI certification from suppliers are effectively requiring that your microbiology program satisfy these scheme clauses. Many then add customer specific requirements, for example, pathogen test frequencies, microbiological criteria, and lab accreditation expectations that go beyond the scheme minimum.

How BRCGS, SQF, FSSC 22000, and PrimusGFS frame microbiology

While each scheme has its own structure, there is a shared pattern.

BRCGS Food Safety Issue 9 includes clauses on product testing, environmental monitoring, and laboratory controls. It requires that laboratories demonstrate competence, which auditors commonly interpret as ISO 17025 accreditation with relevant scope.
SQF Edition 9 requires product testing to verify the food safety plan and describes environmental monitoring expectations for RTE and high risk zones. Scheme guidance and auditor training materials reinforce the importance of a risk based EMP.
FSSC 22000 Version 6 builds on ISO 22000 and sector specific prerequisite programs such as ISO/TS 22002-1. These prerequisite programs include sanitation verification, environmental monitoring, and product testing expectations which auditors review within the wider food safety management system.
PrimusGFS, used heavily in fresh produce and fresh cut operations, includes detailed environmental and product testing requirements that reflect the specific Listeria and E. coli O157:H7 risks in fresh produce.

The language differs, however auditors trained on these schemes converge on the same core questions. Is testing risk based and documented? Are laboratories competent and, ideally, accredited? Are results used for trend analysis and corrective action, or only filed?

Customer and retailer requirements on top of scheme minimums

Many mid sized manufacturers supply multiple retailers, private label customers, and foodservice brands. Their internal codes of practice often specify:

Pathogen test frequencies for defined product categories.
Specific microbiological criteria or tighter limits than regulations.
ISO 17025 accreditation for all food safety critical testing, sometimes with expectations on method selection.

These customer codes do not replace scheme clauses. They layer on top. A QA team that prepares only to the scheme minimum can still face non conformity during a customer technical review, which carries commercial consequences even if the certification body is satisfied. Mapping your microbiology program to both the scheme and key customer manuals is now part of baseline governance.

What Auditors Actually Bring To The Table

How auditors are trained to evaluate microbiology

Certification body auditors working under GFSI benchmarked schemes are not generalists casually reviewing checklists. Senior auditors usually have technical backgrounds in food science, microbiology, or production, and they are trained in scheme specific audit protocols.

For microbiology, audit protocols direct them to:

Test the link between your hazard analysis and your microbiology program.
Review laboratory competence, scope of accreditation, and method references.
Examine environmental monitoring design and performance, especially in RTE and high risk areas.
Evaluate whether validation and verification activities are clearly distinguished and documented.
Assess trend analysis, investigation records, and management review minutes.

When an auditor asks why you sample environmental Zone 2 at a certain frequency, or how you chose a particular method, they are following a defined audit trail. An absence of evidence is not simply inconvenient. It is scored.

Typical auditor questions leaders should anticipate

Executives who sit in on opening and closing meetings will hear recurring themes in auditor questions:

How did you determine your microbiological testing frequencies and criteria?
How did you qualify your external laboratories, and how do you monitor them?
Can you walk through a recent environmental positive and show investigation and corrective action records?
How does your microbiology data feed back into the hazard analysis and management review?
What validation documentation do you have for key controls such as thermal processes, pH or water activity hurdles, or shelf life limits?

Teams that answer these questions with clear, documented rationale and traceable evidence tend to have smoother audits. Teams that rely on “this is how we have always done it” find themselves debating nonconformances that could have been avoided with better governance.

Why Laboratory Accreditation And Method Choice Are Non Negotiable

What ISO 17025 accreditation really means for your program

ISO/IEC 17025 is the international standard for testing and calibration laboratories. Accreditation requires independent assessment by a recognized accreditation body, covering quality management, technical competence, method validation, calibration, proficiency testing, and personnel qualifications. For food microbiology, scope is critical. A lab may be accredited for aerobic plate count on dairy but not for Listeria monocytogenes detection in RTE meat.

Under GFSI schemes, the practical expectation is that laboratories performing food safety critical tests demonstrate competence through ISO 17025 accreditation for the specific test, method, and matrix in question. Accreditation bodies conduct surveillance and reassessments, meaning scopes and status can change over time. QA teams that validated lab accreditation years ago and never checked again carry hidden risk into every audit.

Recognized methods auditors expect to see

Auditors expect microbiology test reports to reference recognized, validated methods. In practice that usually means:

ISO methods.
AOAC Official Methods or Performance Tested Methods.
Health Canada HPB methods for Canadian regulatory contexts.
FDA BAM methods in some North American programs.
USP microbiology chapters for certain ingredients and pharma adjacent products.

When a certificate of analysis references only an internal method number, or an undocumented house method, auditors will ask for validation evidence. If that evidence is not available, the testing itself becomes difficult to defend, even if the numerical result appears acceptable.

How non accredited labs and improvised methods surface as findings

In many plants, non accredited labs or improvised methods are legacy decisions. Perhaps a local lab was used before ISO 17025 was emphasized, or a lower cost provider was approved without a full scope review. In other cases, in house microbiology testing evolved organically, without the governance that ISO 17025 requires.

These gaps surface when auditors:

Ask for accreditation certificates and do not see relevant methods or matrices in the scope.
Review test reports and find unrecognized method references.
Probe the validation basis for rapid tests, ATP systems used as food safety verification, or in house methods.

Corrective actions usually involve migrating to accredited labs, documenting method validation or verification, and strengthening supplier approval for labs. The reputational and commercial cost of a major nonconformance, however, is significantly higher than the cost of building a robust lab strategy before the audit.

What “Good” Looks Like For Your Lab Strategy

Leadership level criteria for selecting and qualifying labs

A well governed lab strategy treats external labs as critical suppliers. That means:

Verifying ISO 17025 accreditation and confirming that scope covers the specific tests, methods, and matrices you use.
Reviewing proficiency testing participation and performance.
Assessing turnaround time reliability and communication processes for abnormal results.
Understanding sample handling, chain of custody, and data integrity controls.
Confirming the lab’s ability to support investigations and provide defensible documentation if results are challenged by regulators or customers.

For high risk testing such as finished product pathogen detection, environmental pathogen confirmation, or kill step validation studies, the lab’s scientific depth and ability to assist with study design and interpretation are additional selection criteria.

Treating labs as critical suppliers with ongoing governance

Under most GFSI schemes, external laboratories used for food safety verification fit within your supplier approval and monitoring program. Governance elements typically include:

Annual review of accreditation certificates and scopes.
Periodic performance evaluation, for example, missed turnaround times or data corrections.
Documented processes for approving new methods and responding to scope changes at the lab.
Clear escalation paths when lab results suggest a potential safety issue.

A lab that quietly drops a method from its accredited scope while your plant continues to rely on that method is a classic example of a governance gap that auditors are trained to find.

Designing A GFSI Ready Microbiology Program

Shifting from incremental testing to system design

Many plants have microbiology programs that grew by accretion. A finished product test added after a customer complaint, an EMP program built under pressure from an inspector, a challenge study commissioned when a new product struggled with shelf life. The end result is activity without clear architecture.

A GFSI ready program starts with the hazard analysis. The microbiological hazards identified in your food safety plan, whether under a CFIA Preventive Control Plan, HACCP, or ISO 22000, should drive:

Which products and ingredients are tested.
Which hazards are targeted.
What frequencies and sampling plans are used.
Which criteria define acceptance, rejection, or investigation.
How results feed into corrective action and review.

Programs that cannot trace tests back to hazard and risk rationale are exposed in audits, even if they generate a high volume of results.

How product risk, process design, and customers shape the program

A defensible microbiology program reflects three inputs.

Product and ingredient risk, for example, RTE meat versus dry snack, dairy versus oil.
Process design and controls, such as validated thermal steps, pH and water activity barriers, packaging, and cold chain.
Customer and regulatory requirements, including scheme clauses, national regulations, and private codes of practice.

A high care RTE facility under BRCGS with Listeria as a key hazard will build a program that looks very different from a dry ingredient blender under SQF focusing on Salmonella in low moisture environments. Applying a generic template across both plants creates blind spots that auditors and regulators recognize immediately.

Aligning routine testing, EMP, validation, and verification

Under GFSI expectations, routine product testing, environmental monitoring, validation, and verification are pieces of a single system. Common integration points include:

EMP results informing sanitation verification and potential adjustments to product testing.
Finished product and ingredient testing trends feeding into hazard analysis review.
Validation studies serving as the scientific basis for critical limits, which are then verified through routine monitoring and testing.
Internal audits and management review sessions examining microbiology trends and the effectiveness of corrective actions.

Auditors want to see this system logic in your documentation. If product testing, EMP, and validation are handled by different departments, recorded in different systems, and rarely reviewed together, it is difficult to demonstrate that you have a coherent microbiology control strategy.

Finished Product And Ingredient Testing That Holds Up In Audits

Risk based sampling and criteria

GFSI schemes generally avoid prescribing specific finished product testing frequencies. Instead, they require that frequencies and criteria be risk based and documented. This distinction is not a technicality.

Two plants might test at the same frequency. The plant that can show a rationale based on product type, process lethality, volume, history, regulatory expectations, and ICMSF concepts is in a stronger audit position than the plant that simply says “this is what we have always done.”

ICMSF guidance on sampling plans and lot acceptance provides a useful scientific reference for designing and justifying sampling strategies. Leaders do not need to be statisticians, but they should expect their teams to be able to explain why a particular n, c, m, M plan or presence/absence approach is appropriate and what risk it manages.

How auditors review finished product testing programs

When auditors review certificates of analysis, they look for:

Documented sampling plans with rationale, not just ad hoc sampling.
Defined microbiological criteria that align with regulations, scheme expectations, and customer requirements.
Evidence of trend analysis, including how many lots are tested, how often, and how results are evaluated.
Investigation records when results are out of specification or show concerning trends.
Clear links to hazard analysis and management review minutes.

A binder full of passing results with no trend charts, no investigations, and no management notes is a warning sign. It suggests a program that generates data but does not use it.

Ingredient testing and supplier risk

Ingredient testing expectations mirror finished product logic, but add a supplier dimension. Typical expectations under BRCGS and SQF include:

Risk assessments that differentiate high risk ingredients (for example, RTE components, spices, nuts, leafy greens) from lower risk inputs.
Incoming testing programs that reflect this differentiation, with more rigorous testing for higher risk materials.
Integration of supplier performance and test results into supplier approval and monitoring programs.

In practice, auditors will select a high risk ingredient, review its risk assessment, sampling plan, test results, and documented responses to nonconformances. If the story does not hang together, both the ingredient program and the supplier program can be affected.

Environmental Monitoring Programs Under GFSI Scrutiny

Designing an EMP that finds problems

Environmental monitoring has become one of the most scrutinized areas in GFSI audits, particularly for RTE, high care, and high risk operations, as well as for categories such as fresh produce and low moisture foods where environmental contamination has driven outbreaks.

Auditors are not impressed by an EMP that never finds anything. A program with very limited sites, long intervals between samples, avoidance of hard to reach locations, and minimal Zone 1 work in high risk areas looks like it was designed to avoid bad news. That pattern usually attracts findings.

Core design elements auditors examine

Key elements of a defensible EMP include:

A documented zone map with clear definitions for Zones 1 to 4 that reflect actual plant layout.
A list of sample sites with rotation plans that cover drains, equipment legs, framework, and other likely harborage points, not only easy to access surfaces.
Target organisms that match risk, for example, Listeria species in RTE cold areas, Salmonella in dry processing, and indicator organisms where hygiene verification is the main goal.
Sampling frequencies that increase in higher risk zones and are supported by risk justification.
Defined action limits and decision trees for follow up when results exceed those limits.

Documentation that proves a living EMP

Documentation that tends to impress auditors includes:

Dated zone maps and updated site lists reflecting equipment or layout changes.
Rotation records showing variation in sampled sites over time.
Investigation reports for positive or elevated results with root cause analysis.
Records of enhanced sampling and re testing after corrective actions.
Evidence that EMP trend data is reviewed at defined intervals in management review.

By contrast, gaps that frequently generate major nonconformances include:

Outdated maps that ignore new lines or equipment.
No sampling in drains, floor-wall junctions, or complex equipment.
Action limits that exist on paper but have never triggered an investigation.
Corrective action records that report cleaning and retesting but no root cause analysis.

Common EMP patterns that lead to findings

Two recurring patterns stand out:

EMP results are not linked to finished product testing, sanitation verification, or hazard analysis. Environmental positives do not trigger changes in product sampling plans, nor do they appear in management review.
EMP data is collected but not trended. There are no charts or summaries, only raw reports. Without trend analysis, the plant may miss recurrent hot spots or seasonal patterns that an auditor will spot quickly.

These issues signal that the program is not being used as a control tool.

Pathogens, Indicators, And Hygiene Tools In The Auditor’s Eyes

What each testing layer is for

A robust microbiology program uses several layers of testing. Each has a specific role and limitation. Confusing them is a common and visible weakness.

ATP bioluminescence verifies cleaning by detecting organic residue. It does not detect microorganisms or confirm pathogen control.
Indicator organisms such as Enterobacteriaceae, coliforms, or aerobic plate counts assess hygiene and process control. They indicate conditions that might support pathogens but their absence does not guarantee safety.
Listeria species swabbing in the environment is an indicator program for Listeria monocytogenes harborage. Positive results generally trigger speciation and targeted cleanup.
Pathogen specific methods for Salmonella, Listeria monocytogenes, or E. coli O157:H7 provide direct evidence about key hazards, but a negative test still represents a sample based assurance, not an absolute guarantee.

Auditors expect each layer to be used in line with its purpose. They are particularly alert to programs that present ATP data as primary verification of pathogen control.

Summary table: expected role of each layer

Testing layer	Primary purpose	Key limitations	Audit defensibility notes
ATP bioluminescence	Cleaning verification and organic residue detection	Does not detect microorganisms or specific hazards	Accepted as a sanitation monitoring tool, not as evidence of pathogen control
Indicator organisms (for example APC, coliforms, Enterobacteriaceae)	Process hygiene verification and trend monitoring	Absence does not confirm pathogen absence	Strong when used within a broader EMP and trended over time
Listeria species environmental swabbing	Indicator of Listeria monocytogenes harborage	Species level results, follow up speciation is required	Standard in RTE environments, auditors expect clear response procedures
Pathogen specific testing with recognized methods	Direct detection of target pathogens in product or environment	Negative results provide sample based assurance only	Highest defensibility when performed by ISO 17025 accredited labs using recognized methods

Programs that rely heavily on ATP and indicator results while avoiding environmental pathogen testing in high risk areas are structurally exposed. The reverse is also true. Plants that run expensive pathogen tests but neglect basic hygiene indicators and trend analysis may lack the operational feedback needed to improve sanitation and process control.

Why over reliance on ATP attracts findings

ATP systems are valuable operational tools. They allow supervisors to verify cleaning within minutes and coach crews in real time. The audit problem arises when ATP pass rates are presented as evidence that Listeria or Salmonella are under control.

An auditor who sees a food safety plan that lists ATP data as the main verification step for a critical control point that is supposed to control pathogens will question the scientific basis of the plan. The corrective path usually includes adding appropriate microbiological tests, adjusting EMP design, and clarifying in documentation what ATP is and is not intended to demonstrate.

Validation, Verification, And Documentation Leaders Must Govern

Getting the validation versus verification distinction right

Validation and verification appear across all major GFSI schemes, CFIA Preventive Control Plan guidance, and FSMA preventive controls rules. Auditors are specifically trained to test whether a plant understands the difference.

Validation asks whether a control measure works as intended. For example, does a thermal process achieve the required log reduction of a pathogen in a specific product under defined worst case conditions?
Verification asks whether that control measure continues to operate as intended in day to day production. Examples include calibration records, routine product testing, environmental monitoring, and internal audits.

Many plants have detailed verification records, such as temperature charts and calibration certificates, but lack a validation document that ties those operating parameters to scientific lethality data or challenge study results. This is a common and material finding for thermal steps, pH or water activity controls, and shelf life limits.

Scenario: missing kill step validation in an RTE process

A specialty manufacturer launched a marinated RTE poultry line under an existing FSSC 22000 certification. The cooking step had a defined internal temperature and time, and verification records showed that these conditions were consistently met.

During the certification audit, the auditor requested the validation basis for the critical limit at the cooking step. The plant did not have a documented validation study or literature review demonstrating that the time and temperature combination achieved the required log reduction of Salmonella in the specific product.

The auditor issued a major nonconformance. Verification records confirmed that the process ran as specified. They did not prove that the specification itself was scientifically adequate.

The manufacturer closed the gap by:

Commissioning a retrospective validation package that included a review of relevant published data and an applicability assessment for its product.
Documenting a validation conclusion endorsed by a qualified food safety professional, with review by an accredited laboratory.
Updating new product development procedures to require validation documentation before commercial launch.

This scenario shows how validation governance must sit upstream in product and process design, not only in audit preparation.

Documentation stack auditors will challenge

Executives should expect auditors to review:

Validation reports, literature reviews, and challenge study summaries for key controls.
Verification records such as temperature logs, EMP data, and finished product testing.
Corrective action reports that show how deviations were handled and how recurrence is prevented.
Internal audit reports focused on microbiology related clauses.
Management review minutes that discuss microbiology performance, trends, and needed changes.

Programs that treat validation as a one time activity with no review after significant product, process, or equipment changes are exposed, particularly under CFIA and FSMA expectations.

A Practical Framework To Assess GFSI Readiness Of Your Microbiology Program

Leaders need a way to assess microbiology programs at a system level. A simple four step framework can help organize that review.

Step 1: Map risks, schemes, and regulatory anchors

List product categories, processes, markets, and customers.
Identify applicable schemes (for example, BRCGS, SQF, FSSC 22000, PrimusGFS) and relevant regulatory frameworks (CFIA and SFCR, Health Canada policies, FSMA where relevant).
For each product and process family, identify key microbiological hazards and reference standards that apply, such as Health Canada or FDA criteria, ICMSF guidance, or scheme specific codes.

Step 2: Design or rebuild the program architecture

For each hazard and product family, document how finished product testing, ingredient testing, and EMP address the risk.
Confirm that test frequencies, methods, and criteria are risk justified and documented, not historical habits.
Align laboratory selection and method choices with the accreditation and recognition expectations of schemes and key customers.

Step 3: Validate, verify, and trend

Identify which controls require formal validation (for example, thermal processes, formulation hurdles, shelf life limits) and assess whether validation documentation exists and remains current.
Confirm that verification activities, including testing and monitoring, are aligned to validated parameters.
Review trend analysis for product and environmental results, and confirm that trends are discussed at the right level of management.

Step 4: Govern, document, and re evaluate

Ensure that external labs are treated as critical suppliers, with annual checks on accreditation scope and performance.
Integrate microbiology topics into internal audits and management review, with clear actions and follow up.
Define triggers for program re evaluation, including new products, process changes, recurring positives, or changes in scheme or regulatory expectations.

This framework is not a replacement for scheme specific guidance, but it gives executives a structure for asking the right questions and prioritizing improvements.

Scenarios: How Microbiology Programs Pass Or Fail GFSI Audits

Scenario 1: Strong EMP, weak lab governance

A mid sized RTE facility invested heavily in an EMP. The program had robust zone mapping, weekly swabbing in Zones 2 and 3, and increased sampling after sanitation. Trend charts were posted in QA offices.

During a BRCGS audit, the auditor praised the EMP design, then asked which laboratory handled confirmation testing. The lab used for Listeria confirmation did not hold ISO 17025 accreditation for that method and matrix. The plant had validated the relationship years earlier but had not rechecked accreditation scope since.

The auditor raised a major nonconformance on laboratory competence for food safety critical testing. Corrective actions required qualifying a new lab, updating supplier approval documentation, and retesting retained samples for recent positives. The EMP itself was sound, but weak lab governance undermined its audit defensibility.

Scenario 2: Multi site processor with inconsistent practices

A multi site processor operated three plants under SQF certification. Each site had developed its microbiology program independently.

Site A used an accredited lab for all testing and had a documented sampling plan that explicitly referenced hazard analysis.
Site B used two labs, one accredited and one not, and had inconsistent method references across products.
Site C had a strong EMP but limited finished product testing, justified informally as “low risk products.”

When the certification body rotated auditors, one auditor reviewed all three sites in a single cycle and quickly spotted inconsistencies. The company had a corporate food safety policy, but no standardized microbiology program or lab qualification protocol across sites.

The audit findings included minor and major nonconformances for inconsistent application of the company’s own policies and scheme requirements. Leadership responded by standardizing lab approval, method selection, and minimum expectations for product and EMP testing, with flexibility only where documented risk assessments justified differences.

Scenario 3: New product launch with incomplete validation

A refrigerated RTE meal manufacturer under FSSC 22000 introduced a new product line with innovative packaging and an extended shelf life claim. Microbiological shelf life was validated using a limited challenge study, but the study did not include abuse temperature conditions that distribution occasionally experienced.

During a surveillance audit, the certification body auditor asked for the validation documentation supporting the shelf life claim. The challenge study report was reviewed and the absence of abuse condition data was flagged. The auditor questioned whether the validation was adequate to support the claim under realistic distribution conditions.

The corrective action involved commissioning an expanded challenge study that included abuse scenarios and revising the shelf life claim temporarily while data was generated. The company also updated its validation procedure to require explicit documentation of distribution and storage assumptions.

In each scenario, the root issue was not a lack of testing, but gaps in governance, alignment, or documentation.

Frequently Asked Questions From Executives On GFSI Microbiology Expectations

Do all GFSI schemes require ISO 17025 accredited labs for microbiology testing?

Scheme language varies, but the practical expectation across BRCGS, SQF, FSSC 22000, and PrimusGFS is that laboratories performing food safety critical tests are demonstrably competent. ISO 17025 accreditation is the most widely recognized way to demonstrate this. Some clauses refer to “recognized” or “competent” laboratories rather than naming ISO 17025 explicitly, yet auditors typically look for accreditation and consider it the benchmark for audit defensibility. Customer codes of practice often go further and explicitly require ISO 17025 accreditation for all safety critical testing.

How often should finished product and EMP testing be conducted to satisfy GFSI and customer expectations?

There is no single frequency that applies across products and plants. Schemes expect frequencies to be risk justified and documented. Higher risk products, processes with less inherent control, and sites with a history of positives or variability will warrant more frequent testing. Lower risk products with strong validated controls may be supported by less frequent verification. Executives should ask their teams to show the rationale behind current frequencies and how those frequencies would change if risk factors shift.

Can in house microbiology labs be used for GFSI verification, and what governance do they require?

In house labs can be used for GFSI related testing, provided they can demonstrate competence and data integrity. Some sites pursue ISO 17025 accreditation for their internal labs, while others rely on rigorous internal quality systems, method verification, and proficiency testing participation. In all cases, auditors expect documented validation or verification of methods, training records for analysts, equipment calibration, and a clear process for confirming critical results with an external accredited lab when needed.

What happens if an environmental or product result is positive near a GFSI audit?

A positive result close to an audit is not automatically a nonconformance. The key question is how the plant responded. Auditors will ask to see investigation records, root cause analysis, corrective actions, and verification of effectiveness, including any enhanced sampling or product disposition decisions. Plants that respond methodically and document both actions and rationale are often viewed more favorably than plants that have no positives but also no evidence of a program designed to find problems.

How do GFSI microbiology expectations interact with CFIA, Health Canada, and FSMA requirements?

GFSI schemes and national frameworks share the same foundations: hazard analysis, preventive controls, validation, and verification. CFIA’s Preventive Control Plan requirements and Health Canada policies influence specifications, method selection, and criteria in Canadian plants. FSMA preventive controls rules and environmental monitoring expectations affect exporters to the United States. A microbiology program that aligns with scheme clauses while also referencing national guidance is generally easier to defend to both auditors and regulators.

How much flexibility do we have to tailor our microbiology program while remaining certifiable?

Schemes deliberately allow flexibility so plants can design programs that match their products and risks. That flexibility is not unlimited. Any deviation from common practice, whether lower test frequencies, reliance on non accredited labs, or limited environmental pathogen work in high risk areas, needs a documented risk assessment and, ideally, discussion with the certification body. Flexibility without documentation looks like noncompliance.

What evidence convinces auditors that our program is a living system rather than a static binder?

Auditors look for:

Trend charts and summaries, not just raw data.
Recent investigation reports and corrective action records.
Management review minutes that discuss microbiology results and needed improvements.
Updates to sampling plans, methods, or frequencies based on data and changes in risk.

They want to see that the program evolves in response to new information and external changes, such as updated schemes or regulatory policies.

Turning Microbiology Expectations Into Strategic Advantage

GFSI microbiology expectations can feel like a burden when viewed only as clauses to satisfy. Leaders who treat them as a blueprint for risk reduction, regulatory defensibility, and operational stability see different opportunities. A well governed microbiology program reduces the likelihood of disruptive audit findings, supports smoother interactions with CFIA, Health Canada, and FDA, and provides credible evidence to retailers and brand owners that your controls are serious.

Practical next steps include commissioning a structured gap assessment of your microbiology program against scheme, regulatory, and customer expectations, and consolidating or re qualifying laboratory partners with clear governance over methods, scope, and performance. From there, updating EMP design, validation documentation, and trend analysis routines becomes far easier.

If you want to pressure test how audit defensible your current microbiology program really is, and explore where ISO 17025 accredited testing and stronger documentation could reduce risk, contact Cremco Labs to discuss a compliance first assessment tailored to your plant configuration, product portfolio, and customer landscape.